ALS, a Rare but Deadly Disease, can Silence Anyone. Here’s What to Know.
Washington Post - 11/14/22
Anyone can be affected by the relatively rare amyotrophic lateral sclerosis, known as ALS or Lou Gehrig’s disease, according to experts.
Parkinson's vs. Essential Tremor: What's the Difference?
US News & World Report - 11/10/22
Many people associate involuntary shaking of the body with Parkinson’s disease, a neurodegenerative disease that affects an individual's movement. But while this uncontrollable trembling is a hallmark sign of Parkinson's disease, it is often mistaken for another – more common – neurological movement disorder: essential tremor.
Emory Healthcare First in Georgia to Offer Non-Invasive Focused Ultrasound Treatment for Tremor
Emory - 9/14/22
Emory Healthcare is the first health care system in Georgia offering a non-invasive ultrasound treatment for patients living with essential tremor or tremor from Parkinson’s disease.
Find Calm to Carry On
Simply Buckhead - 8/25/22
Physically healthy people who avoid social interactions should seek help, says Dr. Toby Goldsmith, a psychiatrist at the Emory Brain Health Center in Brookhaven, who directs the Emory Women’s Mental Health Program. “It’s important to attempt to maintain some level of normalcy.”
Study Finds Depression is Not Likely Caused by a Chemical Imbalance or Low Serotonin Levels
Fox 5 - 8/23/22
When it comes to understanding what causes major depressive disorder, Emory psychiatrist Dr. Boadie Dunlop says the answer is complicated.
5 Keys to Building an Emotionally Healthy Relationship with Competing
Dance Magazine - 8/15/22
“When competitiveness impacts your mood and your relationships with others, and when it gets in the way of feeling good about yourself, then it’s problematic,” says Dr. Nadine Kaslow, a psychologist who works with dancers and students at Atlanta Ballet.
9 Tips for Getting the Neurologic Care You Need Despite Staffing Shortages
Brain & Life - 8/5/22
If it is going to take six months or longer for an in-person appointment, ask about a virtual visit, especially if it's the initial step in an evaluation, says Taylor B. Harrison, MD, associate professor of neurology at Emory University School of Medicine in Atlanta.
Is Reversing Early-Stage Alzheimer’s Disease Possible? A New Study Finds it May Be
GPB - 7/11/22
“Our approach to personalized medicine is with the recognition that there are these lifestyle factors like sleep, exercise and diet,” Levey said. “[Factors] like the degree of social interaction, [and] there are genetic factors, there's ancestry.”
This Emory Alzheimer’s Researcher Is Working To Boost Diversity in Research
Being Patient - 6/30/22
Alzheimer’s and dementia research is personal to Emory University’s Dr. Monica Parker: Her 96-year-old mother lives with the condition. But, her familial connection is not what directly led to her involvement in research.
Todd Golde Named Emory’s Newest GRA Scholar, Joins Goizueta Institute @ Emory Brain Health
Emory - 6/29/22
Emory University has named Todd E. Golde, MD, PhD, the new director of the Emory Center for Neurodegenerative Disease (CND) in the Goizueta Institute @ Emory Brain Health.
Epilepsy Centers Focus on Unique Needs of Older Adults
Neurology Today - 3/17/22
Diagnosing and treating seizures in older people is important because it could stave off cognitive decline, said Edward Faught, MD, FAAN, professor of neurology at Emory University School of Medicine.
Study Unveils New Protein-Related Changes in the Brain of Patients with Alzheimer's Disease
Medical Xpress - 3/9/22
Researchers at Emory University School of Medicine have recently carried out a large-scale analysis of the brains of patients with Alzheimer's disease.
A New Study Helps Untangle the Role of Tau in Dementia
Wired - 1/26/22
Concentrating on other proteins involved in neurodegenerative diseases could help scientists find new ways to treat them. “Proteins don’t act in isolation,” says Nicholas Seyfried, an associate professor of biochemistry and neurology at Emory University who studies neurodegeneration.
Does Edaravone Slow ALS Progression?
Medpage Today - 1/10/22
The FDA approval of edaravone in 2017 was "somewhat of a surprise to many in the ALS scientific and clinical research communities but was seen by patients as new hope for slowing disease," observed Jonathan Glass, MD, and Christina Fournier, MD, MS, both of Emory University in Atlanta.